Navigation Links
Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile
Date:2/17/2009

ese two regions of the world are estimated to be costing more than $7bn a year. The emergence of a hyper-virulent strain of C. difficile in 2002 further highlighted the importance of tackling CDI.

About the Clinical Trial

The phase IIb trial involves about 600 participants with acute CDI at about 30 centers across the United Kingdom. Participants will be randomized to 4 study groups, where three groups will receive vaccine, while the fourth group will be given a placebo vaccine. All subjects will receive standard of care antibiotics.

About C. difficile

C. difficile is an anaerobic spore-forming bacterium, present asymptomatically in approximately 60% of infants but only about 3% of healthy adults. It belongs to the Clostridium family of bacteria, which also includes C. tetani (tetanus) and C. botulinum (botulism). The C. difficile bacteria produce two potent toxins: A and B. When the natural microbial flora of the gut is disturbed, usually as a result of antibiotic treatment, and a patient ingests C. difficile spores, the bacteria can multiply and release the two toxins, which cause gastrointestinal pathologies in humans known collectively as CDI.

Hospital-acquired infections caused by C. difficile bacteria are a considerable problem in many industrialized countries, including the U.S., Canada, and Europe. It is estimated that C. difficile causes about 500,000 cases in the US alone (1) with annual costs to the healthcare system of $3.2bn.(2) In the EU, assuming a population of about 460 million people, the healthcare costs of CDI are estimated to be around $4.4bn per year.(3) Additional information is available at the UK Health Protection Agency C. difficile information page (4) and at http://www.sanofipasteur.com/cdiff

About sanofi-aventis

Sanofi-aventis, a leading global pharmaceutica
'/>"/>

SOURCE Sanofi Pasteur
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin
2. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
3. Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US
4. Sanofi Pasteur to Donate 60 Million Doses of H5N1 Vaccine to WHO Over 3 Years for its Influenza Vaccine Global Stockpile
5. Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine
6. Sanofi Pasteur Receives FDA Approval of Meningococcal Vaccine for Children
7. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
8. Clinical Update - Debio 9902 SR (ZT-1) for Alzheimer Patients Debiopharm Starts Tablet Formulations Bridging Study under IND
9. Presbyterian Hospital Dallas Starts Advanced Breast-Cancer Risk-Assessment Program
10. U.S. NCI Starts Enrolment in Phase 2 Systemic Melanoma Clinical Trial with REOLYSIN(R)
11. BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  MGC Diagnostics Corporation (NASDAQ: ... medical technology company, today scheduled a conference call to ... fiscal year 2013, ended April 30, 2013. The call ... 30, 2013. The Company will report financial results for ... markets close on Thursday, May 30, 2013. ...
(Date:5/23/2013)... 2013  Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: ... based on intellectual property developed and owned by ... foremost medical research center, today announced that its ... funding from the Israeli Ministry of Industry and ... support product development and advance clinical trials. Cell ...
(Date:5/23/2013)... Calif. , May 23, 2013 Anthem ... program that would have required them to obtain their ... by Consumer Watchdog and Whatley Kallas LLC.  ... Superior Court, alleged that Blue Cross,s mandatory mail order ... threatening their health and privacy. "This settlement ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3
(Date:5/24/2013)... Atlanta, GA (PRWEB) May 24, 2013 CBT ... of Sales. Gonter joins the web-based retail automotive industry news ... sales. , “I’m excited to join a group that’s ... a perfect example of how online video content is on ... career in the motorcycle business and segued into advertising at ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Electric™ Energy Straws, ... fueling IndyCar Rookie Carlos Munoz and will be the lead ... 500 at the Indianapolis Motor Speedway. Munoz, who is part ... speed of 228.342 mph in race, qualifying to be named ... the first row in Sunday’s race. , While Munoz ...
(Date:5/24/2013)... York, NY (PRWEB) May 24, 2013 ... Antigua (AICASA) has signed an articulation agreement with ... their students to study abroad in Antigua. ... three college credits after participating in a cell biology ... an articulation agreement with American University of Antigua ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 The ... of products used outside the central laboratory, by ... a healthcare practitioner or by consumers. This includes ... fertility and pregnancy, infectious and cardiovascular disease and ... such as critical care, surgical and emergency departments. ...
(Date:5/24/2013)... missed more than half of recommended well-child visits had ... children who attended most of their visits, according to ... of Managed Care . The study included more than ... Children with chronic conditions like asthma and heart disease ... missed visits, according to the study. In fact, ...
Breaking Medicine News(10 mins):Health News:Unistraw Electric™ Energy Straw Chevy Car Powers Indianapolis 500 Rookie Driver Carlos Munoz 2Health News:Unistraw Electric™ Energy Straw Chevy Car Powers Indianapolis 500 Rookie Driver Carlos Munoz 3Health News:AICASA Signs Articulation Agreement with Old Dominion University to Create Study Abroad Program 2Health News:Point of Care Diagnostics Market (POC) Analysis and 5 Year Forecast in New Research Report at ReportsnReports.com 2Health News:Point of Care Diagnostics Market (POC) Analysis and 5 Year Forecast in New Research Report at ReportsnReports.com 3Health News:Young children who miss well-child visits are more likely to be hospitalized 2Health News:Young children who miss well-child visits are more likely to be hospitalized 3
... Kathleen Doheny HealthDay Reporter , MONDAY, ... may help breast cancer patients and their doctors ... mastectomy. One study finds that about half ... had a mastectomy with immediate reconstruction develop complications ...
... , MONDAY, Sept. 20 (HealthDay News) -- The intravenous administration ... to treat hospitalized patients suffering from either severe headaches or ... Goadsby, of the Headache Group in the department of neurology ... findings in the Sept. 21 issue of Neurology ...
... soaking from Typhoon Fanapi, and NASA and JAXA,s TRMM satellite ... system before it made landfall this weekend. NASA,s Aqua and ... before the Taiwan landfall, and as it was making landfall ... Rainfall Measuring Mission satellite known as TRMM captured an image ...
... CLEMSON, S.C. A Clemson biochemist has received grants totaling ... cause cancer and genetic illnesses. The U.S. Department of Defense ... Cao three-year funding to investigate two DNA repair pathways. ... understand the basic mechanisms of DNA repair but also help ...
... BETHESDA, Md., Sept. 20, 2010 The American Society for ... of the National Institute of General Medical Sciences, the winner ... Award. Berg will receive the award this evening at an ... "Dr. Berg has been a true champion of investigator-initiated research, ...
... of Utah determined that the 2009 pandemic influenza A ... children than the seasonal flu. The most common ... of the study, the most extensive evaluation of neurological ... the September issue of Annals of Neurology , ...
Cached Medicine News:Health News:Breast Reconstruction After Mastectomy: Now or Later? 2Health News:Breast Reconstruction After Mastectomy: Now or Later? 3Health News:IV Aspirin Drip Appears to Be Safe, Effective for Migraine 2Health News:NASA captures very heavy rain in Typhoon Fanapi and 2 landfalls 2Health News:Biochemist studies DNA repair with $787,000 in grants 2Health News:National Institute of General Medical Sciences chief wins prestigious public service award 2Health News:Higher incidence of seizures seen in children with H1N1 virus compared to seasonal flu 2
Inquire...
Inquire...
... wall of the serum tube is specially ... activate the coagulation process. Serum / gel ... base of the tube; during centrifugation, this ... serum and the blood cells. In the ...
BD Vacutainer® Plus Plastic Serum Tubes have spray-coated silica and are used for serum determinations in chemistry, serology, and immunohematology....
Medicine Products: